Publications:
“The Evolution of Library Design: Crafting Smart Compound Collections for Phenotypic Screens.” K. Spear, S. Brown, Drug Discov. Today Technol. 23C, 63 (2017).
“In Vivo Phenotypic Drug Discovery: Applying a Behavioral Assay to the Discovery and Optimization of Novel Antipsychotic Agents.” L. Shao, U. Campbell, K. Fang, N. Powell, J. Campbell, P. Jones, T. Hanania, V. Alexandrov, I. Morganstern, E. Sabath, H. Zhong, T. Large, K. Spear; Med. Chem. Commun. 7, 1093 (2016).
Campbell RM, Dymshitz J, Eastwood BJ, Emkey R, Greenen DP, Heerding JM, Johnson D, Large TH, Littlejohn T, Montrose C, Nutter SE, Sawyer BD, Sigmund SK, Smith M, Weidner JR, and Zink RW. Data Standardization for Results Management. In: Sittampalam et al (editors). Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-2017. https://ncats.nih.gov/expertise/preclinical/agm. PMID: 22553865.
Invited Presentations:
2017 Drug Discovery USA Congress
2017 Harvard “Guppy Tank” Review Panel
2017 Non-academic careers. UCLA – Caltech MSTP Retreat
2016 Shanghai BioForum: A Global Solution to the Crisis in Psychiatric Drug Discovery.
2016 Keystone Symposium on Modern Phenotypic Drug Discovery – Defining the Path Forward: Discovery of Novel Psychiatric Drugs Using a Target-Agnostic, Systems Neurobiology Strategy.
2015 Inaugural Partners Health World Medical Innovation Forum – Neurosciences